Assessing insulin effectiveness at the end of the day: Once-daily versus twice-daily insulin glargine injection

ISSN Print: 2160-5831
ISSN Online: 2160-5858
www.scirp.net/journal/jdm
E-mail: [email protected]

Citations

"Assessing insulin effectiveness at the end of the day: Once-daily versus twice-daily insulin glargine injection"
written by Mark R. Burge, Eric R. Schroeder, Stephen Mitchell,
published by Journal of Diabetes Mellitus, Vol.2 No.2, 2012

has been cited by the following article(s):

[1]	Insulin Glargine in Critically ill Patients: Once/Day versus Twice/Day Dosing
	2020

[2]	Proportion and clinical profile of type 1 diabetes patients with a clinical time‐action of insulin glargine U100 shorter than 24 hours
	2020

[3]	Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus
	2019

[4]	INSULIN GLARGINE DOSING EVERY 16 HOURS FOR A COMPLICATED TYPE I DIABETIC CASE
	AACE Clinical Case Reports, 2015

[1]	Insulin Glargine in Critically ill Patients: Once/Day versus Twice/Day Dosing Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2020 DOI:10.1002/phar.2373

[2]	Proportion and clinical profile of type 1 diabetes patients with a clinical time‐action of insulin glargine U100 shorter than 24 hours Practical Diabetes, 2020 DOI:10.1002/pdi.2274

[3]	Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus Journal of Clinical & Translational Endocrinology, 2019 DOI:10.1016/j.jcte.2018.12.002

[4]	Insulin Glargine Dosing Every 16 Hours for a Complicated Type I Diabetes Case AACE Clinical Case Reports, 2016 DOI:10.4158/EP151093.CR